Catalyst
Slingshot members are tracking this event:
Bayer Terminates Phase II Study with Riociguat in Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BAYN.F | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 12, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Riociguat, Pulmonary Hypertension, Idiopathic Interstitial Pneumonia
